SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001679363-22-000027
Filing Date
2022-05-04
Accepted
2022-05-04 08:06:51
Documents
14
Period of Report
2022-05-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K morf-20220504.htm   iXBRL 8-K 35740
2 EX-99.1 morf-2022054x8kex991.htm EX-99.1 60181
6 image_1a.jpg GRAPHIC 5938
  Complete submission text file 0001679363-22-000027.txt   248098

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT morf-20220504.xsd EX-101.SCH 1912
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT morf-20220504_lab.xml EX-101.LAB 23924
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT morf-20220504_pre.xml EX-101.PRE 12606
8 EXTRACTED XBRL INSTANCE DOCUMENT morf-20220504_htm.xml XML 10845
Mailing Address 35 GATEHOUSE DRIVE A2 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE A2 WALTHAM MA 02451 9787296480
Morphic Holding, Inc. (Filer) CIK: 0001679363 (see all company filings)

IRS No.: 473878772 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38940 | Film No.: 22889890
SIC: 2834 Pharmaceutical Preparations